Skip to content

Meet our Team

We are a team of innovators, scientists, and physicians, collectively driven to create therapies that change lives.

Collaboration
is at our core

We are committed to partnering
with the SCI Community to
restore movement, function,
and independence

Our story

Watch video

We benefit from a research partnership with .NeuroRestore, a collaboration between the Swiss Federal Institute of Technology (EPFL) and Lausanne University Hospital (CHUV) that develops and applies bioengineering and neurosurgical strategies to restore neurological functions, particularly those impacted by paralysis.

We also collaborate with other leading research and clinical institutions, such as those that participated in the Up-LIFT pivotal trial and other studies.

We have exclusively licensed intellectual property developed at many leading global neuroscience research institutions, such as the University of Louisville and Caltech.

Meet two of our Co-Founders

    • G Courtine, PhD

      Groundbreaking neuroscientist and winner of the IET A. F. Harvey Engineering Research Prize, the Rolex Award, the Schellenberg Research Prize, the Leenaards Foundation Science Prize, and the Chancellor’s Award from the University of California. Full Professor of Neuroscience and Neurotechnology at EPFL and Director of .NeuroRestore. Holds a PhD in Neurosciences from INSERM Paris and the faculty of Medicine of the University of Pavia, Italy.

    • Jocelyne Bloch, MD

      Celebrated neurosurgeon and winner of the Tasker and Leenaards Prizes for her contribution to research and innovation in the field of neuromodulation. Head of the Department of Functional Neurosurgery at CHUV. Adjunct Professor of Neurosurgery at EPFL and Associate Professor at the University of Lausanne. Director of .NeuroRestore.

    Connect with our Team

    Leadership

      Join us

      We are always looking for talented, mission-driven individuals in Europe and the US to help us create technologies and therapies that make a difference.

      Show me open roles

      Learn about our Sustainability Initiatives

      Summary

      Sustainability is integral to the way we do business. The principles that guide us are highlighted in our ONWARD Medical Code and intertwined in how we operate.

      Learn more about our Sustainability initiatives

      Support our Community Partners

      Christopher & Dana Reeve Foundation

      Spinal Research

      Wings for Life

      Praxis

      To register for email alerts,
      sign up on our Contact page

      Fill out the form
      The ONWARD® Medical ARCEX® System is FDA cleared for use in the United States and CE marked in accordance with EU Medical Device Regulation 2017/745. ONWARD ARCIM® and ARCBCI™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

      Indication for Use (US): The ARCEX® System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old who present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).

      Indication for Use (EU): The ARCEX® System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic and with take-home exercises in the home to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).